Cart
sales@molnova.com
Gantofiban
CAS No. 183547-57-1
Gantofiban( —— )
Catalog No. M36175 CAS No. 183547-57-1
Gantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 192 | In Stock |
|
| 10MG | 274 | In Stock |
|
| 25MG | 430 | In Stock |
|
| 50MG | 600 | In Stock |
|
| 100MG | 820 | In Stock |
|
| 200MG | 1097 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGantofiban
-
NoteResearch use only, not for human use.
-
Brief DescriptionGantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
-
DescriptionGantofiban is a glycoprotein IIb/IIIa (GP IIb/IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number183547-57-1
-
Formula Weight447.48
-
Molecular FormulaC21H29N5O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(C[C@@H](CN2CCN(CC(OCC)=O)CC2)O1)C3=CC=C(C(NC(OC)=O)=N)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Gly-Arg-Gly-Asp-Ser
Gly-Arg-Gly-Asp-Ser (GRGDS) GRGDS is a cell binding protein domain derived from the cell-binding region of fibronectin.
-
Bersanlimab
Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1), demonstrating anticancer properties and applicable for studying relapsed/refractory multiple myeloma.
-
Bexotegrast
Bexotegrast (PLN-74809) is an orally active and potent inhibitor of αvβ6 and αvβ1 integrins with antifibrotic effects, inhibiting αvβ6 and αvβ1-induced activation of TGF-β.
